Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Dermal macrophages might help regrow hair.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

EMT plays a key role in skin fibrosis and offers new therapy targets.

Collagen networks play a key role in hair loss and follicle miniaturization.

Upadacitinib effectively treats psoriasis and lichen planus together.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

High-dose testosterone with finasteride improves muscle health in males with spinal cord injury.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ongoing research and innovation are crucial for improving skin care and treatment.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Stem cells show promise for hair regrowth, but challenges remain.

Alopecia treatment should use a modern, combined approach to effectively address hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Hair follicle stem cells help skin heal and grow during stretching.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Vaccination is the most effective way to reduce COVID-19 transmission.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.